| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.082 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.015 | 0.8 |